We have observed
4 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after February 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Composition for protection against cell-damaging effects
Composition for use in Mycobacteria vaccination
Composition for use in Mycobacteria therapy